Related Experiment Videos
Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D
J Vassallo1, A C Galizia, P Cuschieri
1St Lukes Hospital, Malta.
Postgraduate Medical Journal
|November 1, 1996
Abstract:
A 67-year-old man on prednisolone and azathioprine for ulcerative colitis, developed severe pneumonia due to Nocardia otitidis caviarum, methicillin-resistant Staphylococcus aureus, a group D Streptococcus and Candida albicans. The patient responded well to aggressive antimicrobial therapy.
Insights
A 67-year-old man with ulcerative colitis developed severe pneumonia from multiple pathogens, including Nocardia and MRSA. Aggressive antimicrobial treatment led to a positive patient outcome.
Area of Science:
- Infectious Diseases
- Immunocompromised Hosts
- Pulmonology
Background:
- Ulcerative colitis (UC) is an inflammatory bowel disease often treated with immunosuppressive medications.
- Prednisolone and azathioprine are common immunosuppressants used in UC management.
- Immunosuppression increases susceptibility to opportunistic infections.
Observation:
- A 67-year-old male patient with UC on prednisolone and azathioprine presented with severe pneumonia.
- The pneumonia was caused by a polymicrobial infection.
- Identified pathogens included Nocardia otitidis caviarum, methicillin-resistant Staphylococcus aureus (MRSA), group D Streptococcus, and Candida albicans.
Findings:
- The patient experienced a severe, life-threatening pneumonia.
- The causative agents represented a diverse range of bacteria and fungi.
- Prompt and aggressive antimicrobial therapy was initiated.
Implications:
- This case highlights the risk of severe, polymicrobial pneumonia in immunosuppressed patients.
- Effective management requires broad-spectrum antimicrobial coverage targeting diverse pathogens.
- Early recognition and aggressive treatment are crucial for favorable outcomes in immunocompromised individuals with severe infections.